How Avio Health Is Rewiring Medicine for the Age of AI<\/i><\/b><\/p>\n
PALO ALTO, Calif.\u00a0<\/span>, July 15, 2025<\/span><\/span> \/PRNewswire\/ — Today, Avio Health announced the launch of its proprietary clinical AI platform, which is designed to unify health data and support the shift toward preventative, personalized care. By integrating lab results, wearable data, genomics, imaging, and patient histories, the platform provides both clinicians and\u2014soon\u2014consumers with a comprehensive, actionable view of health status.<\/p>\n In current healthcare systems, medical and wellness data are often stored in isolated silos. Laboratory tests, imaging results, wearables, and symptom logs typically exist in unconnected systems, limiting the ability to detect trends or anticipate health risks. This fragmentation challenges care providers and leaves patients with large volumes of unstructured, difficult-to-interpret information.<\/p>\n “<\/span>Patients often undergo numerous tests and use multiple health devices, but the volume of data can quickly become overwhelming, especially when there‘<\/span>s no clear correlation to actual health biomarkers,” said Dr. Elvin Siew<\/span>, Founder of Avio Health<\/p>\n Our platform connects those fragmented data points to uncover meaningful patterns. While we currently support clinicians, we‘<\/span>re also preparing to launch a direct-to-consumer model, giving individuals a simple, unified way to better understand and manage their health. We believe this will help reshape the future of healthcare from reactive to truly preventive.”<\/p>\n Addressing a Growing Gap Between Data and Meaning<\/b><\/p>\n A recent The Star Malaysia<\/i> article noted that many individuals using wearable devices and home diagnostics report feeling confused or anxious rather than informed. Despite access to heart rate variability, glucose monitoring, and sleep tracking, most users receive no integrated insight into how those metrics relate to their health trajectory.<\/p>\n We<\/i><\/b>‘<\/span><\/i><\/b>re not adding more data\u2014we<\/i><\/b>‘<\/span><\/i><\/b>re making it meaningful. Avio Health turns scattered health info into clear, proactive plans for real people.”<\/i><\/b><\/p>\n \u2014 <\/i>Dr Siew<\/i><\/p>\n Avio Health‘<\/span>s platform aims to bridge this gap using a proprietary large language model (LLM) specifically trained on medical data. Unlike general-purpose AI systems, Avio‘<\/span>s LLM is designed to interpret complex, multimodal health inputs and identify early patterns that may indicate underlying issues, even before symptoms emerge.<\/p>\n From Complexity to Clarity: Real-World Application<\/b><\/p>\n In one use case, a 42-year-old patient using several health tracking devices and undergoing routine lab tests reported persistent fatigue and brain fog. Traditional diagnostics found no abnormalities. However, when her data, ranging from hormone labs and wearable metrics to historical health records, was analyzed through the Avio platform, the system flagged early signs of mitochondrial dysfunction and inflammation.<\/p>\n Based on this insight, her care team at Emagene.Life implemented a targeted protocol that included nutritional adjustments, peptide therapy, and follow-up testing. Within 90 days, the patient reported significant energy and cognitive clarity improvement.<\/p>\n Platform Highlights<\/p>\n Avio Health‘<\/span>s technology stack includes:<\/p>\n * A proprietary LLM for functional and preventative health applications<\/p>\n * Integration of labs, genomics, imaging, symptoms, and lifestyle data<\/p>\n * Interoperability with electronic health record (EHR) systems and wearable APIs<\/p>\n * Adaptive clinical models that learn and update with new data over time<\/p>\n * A consumer-facing dashboard (in development) for direct health insight and tracking<\/p>\n Scaling Globally for Clinical and Consumer Use<\/b><\/p>\n Avio Health, already deployed in pilot programs across Southeast Asia<\/span> and the United States<\/span>, empowers clinicians in diagnostic labs, longevity clinics, and wellness centers. Building on this momentum, the company is preparing to launch its highly anticipated direct-to-consumer (B2C) platform, giving individuals the power of longevity in their own hands. This upcoming release will allow everyday users to harness Avio‘<\/span>s advanced AI engine to visualize their complete health picture, uncover hidden patterns, and take personalized, proactive steps toward optimized wellness \u2014 all in one intelligent, user-friendly interface.<\/p>\n About Avio Health<\/p>\n Avio Health is a clinical AI company transforming fragmented health data into unified, actionable insights. The platform supports earlier detection, personalized planning, and data-driven prevention by leveraging advanced machine learning models. Headquartered in Kuala Lumpur<\/span>, Avio Health is expanding globally to serve institutional and individual healthcare markets.<\/p>\n \u00a0<\/p>\n \u00a0<\/p>","protected":false},"excerpt":{"rendered":" <\/p>\n How Avio Health Is Rewiring Medicine for the Age of AI<\/i><\/b><\/p>\n PALO ALTO, Calif.\u00a0<\/span>, July 15, 2025<\/span><\/span> \/PRNewswire\/ — Today, Avio Health announced the launch of its proprietary clinical AI platform, which is designed to unify health data and support the shift toward preventative, personalized care. By integrating lab results, wearable data, genomics, imaging, and patient histories, the platform provides both clinicians and\u2014soon\u2014consumers with a comprehensive, actionable view of health status.<\/p>\n In current healthcare systems, medical and wellness data are often stored in isolated silos. Laboratory tests, imaging results, wearables, and symptom logs typically exist in unconnected systems, limiting the ability to detect trends or anticipate health risks. This fragmentation challenges care providers and leaves patients with large volumes of unstructured, difficult-to-interpret information.<\/p>\n “<\/span>Patients often undergo numerous tests and use multiple health devices, but the volume of data can quickly become overwhelming, especially when there‘<\/span>s no clear correlation to actual health biomarkers,” said Dr. Elvin Siew<\/span>, Founder of Avio Health<\/p>\n Our platform connects those fragmented data points to uncover meaningful patterns. While we currently support clinicians, we‘<\/span>re also preparing to launch a direct-to-consumer model, giving individuals a simple, unified way to better understand and manage their health. We believe this will help reshape the future of healthcare from reactive to truly preventive.”<\/p>\n Addressing a Growing Gap Between Data and Meaning<\/b><\/p>\n A recent The Star Malaysia<\/i> article noted that many individuals using wearable devices and home diagnostics report feeling confused or anxious rather than informed. Despite access to heart rate variability, glucose monitoring, and sleep tracking, most users receive no integrated insight into how those metrics relate to their health trajectory.<\/p>\n We<\/i><\/b>‘<\/span><\/i><\/b>re not adding more data\u2014we<\/i><\/b>‘<\/span><\/i><\/b>re making it meaningful. Avio Health turns scattered health info into clear, proactive plans for real people.”<\/i><\/b><\/p>\n \u2014 <\/i>Dr Siew<\/i><\/p>\n Avio Health‘<\/span>s platform aims to bridge this gap using a proprietary large language model (LLM) specifically trained on medical data. Unlike general-purpose AI systems, Avio‘<\/span>s LLM is designed to interpret complex, multimodal health inputs and identify early patterns that may indicate underlying issues, even before symptoms emerge.<\/p>\n From Complexity to Clarity: Real-World Application<\/b><\/p>\n In one use case, a 42-year-old patient using several health tracking devices and undergoing routine lab tests reported persistent fatigue and brain fog. Traditional diagnostics found no abnormalities. However, when her data, ranging from hormone labs and wearable metrics to historical health records, was analyzed through the Avio platform, the system flagged early signs of mitochondrial dysfunction and inflammation.<\/p>\n Based on this insight, her care team at Emagene.Life implemented a targeted protocol that included nutritional adjustments, peptide therapy, and follow-up testing. Within 90 days, the patient reported significant energy and cognitive clarity improvement.<\/p>\n Platform Highlights<\/p>\n Avio Health‘<\/span>s technology stack includes:<\/p>\n * A proprietary LLM for functional and preventative health applications<\/p>\n * Integration of labs, genomics, imaging, symptoms, and lifestyle data<\/p>\n * Interoperability with electronic health record (EHR) systems and wearable APIs<\/p>\n * Adaptive clinical models that learn and update with new data over time<\/p>\n * A consumer-facing dashboard (in development) for direct health insight and tracking<\/p>\n Scaling Globally for Clinical and Consumer Use<\/b><\/p>\n Avio Health, already deployed in pilot programs across Southeast Asia<\/span> and the United States<\/span>, empowers clinicians in diagnostic labs, longevity clinics, and wellness centers. Building on this momentum, the company is preparing to launch its highly anticipated direct-to-consumer (B2C) platform, giving individuals the power of longevity in their own hands. This upcoming release will allow everyday users to harness Avio‘<\/span>s advanced AI engine to visualize their complete health picture, uncover hidden patterns, and take personalized, proactive steps toward optimized wellness \u2014 all in one intelligent, user-friendly interface.<\/p>\n About Avio Health<\/p>\n Avio Health is a clinical AI company transforming fragmented health data into unified, actionable insights. The platform supports earlier detection, personalized planning, and data-driven prevention by leveraging advanced machine learning models. Headquartered in Kuala Lumpur<\/span>, Avio Health is expanding globally to serve institutional and individual healthcare markets.<\/p>\n \u00a0<\/p>\n \u00a0<\/p>\n <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-28019","post","type-post","status-publish","format-standard","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/28019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28019"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/28019\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}